269 related articles for article (PubMed ID: 20628388)
1. Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases.
Cosimelli M; Golfieri R; Cagol PP; Carpanese L; Sciuto R; Maini CL; Mancini R; Sperduti I; Pizzi G; Diodoro MG; Perrone M; Giampalma E; Angelelli B; Fiore F; Lastoria S; Bacchetti S; Gasperini D; Geatti O; Izzo F;
Br J Cancer; 2010 Jul; 103(3):324-31. PubMed ID: 20628388
[TBL] [Abstract][Full Text] [Related]
2. Selective transarterial radioembolisation of unresectable liver-dominant colorectal cancer refractory to chemotherapy.
Golfieri R; Mosconi C; Giampalma E; Cappelli A; Galaverni MC; Pettinato C; Renzulli M; Monari F; Mazzarotto R; Pinto C; Angelelli B
Radiol Med; 2015 Aug; 120(8):767-76. PubMed ID: 25678128
[TBL] [Abstract][Full Text] [Related]
3. A multicentric phase II clinical trial on intra-arterial hepatic radiotherapy with 90yttrium SIR-spheres in unresectable, colorectal liver metastases refractory to i.v. chemotherapy: preliminary results on toxicity and response rates.
Mancini R; Carpanese L; Sciuto R; Pizzi G; Golfieri R; Giampalma L; Cappelli A; Galaverni MC; Blotta A; Fiore F; Izzo F; Lastoria S; Mastro A; Di Marzo M; Cagol PP; Gasparini D; Geatti O; Bacchetti S; Pasqual E; Zeuli M; Paoletti G; Garufi C; Cosimelli M;
In Vivo; 2006; 20(6A):711-4. PubMed ID: 17203751
[TBL] [Abstract][Full Text] [Related]
4. Radioembolisation for liver metastases: results from a prospective 151 patient multi-institutional phase II study.
Benson AB; Geschwind JF; Mulcahy MF; Rilling W; Siskin G; Wiseman G; Cunningham J; Houghton B; Ross M; Memon K; Andrews J; Fleming CJ; Herman J; Nimeiri H; Lewandowski RJ; Salem R
Eur J Cancer; 2013 Oct; 49(15):3122-30. PubMed ID: 23777743
[TBL] [Abstract][Full Text] [Related]
5. Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results.
Murthy R; Xiong H; Nunez R; Cohen AC; Barron B; Szklaruk J; Madoff DC; Gupta S; Wallace MJ; Ahrar K; Hicks ME
J Vasc Interv Radiol; 2005 Jul; 16(7):937-45. PubMed ID: 16002501
[TBL] [Abstract][Full Text] [Related]
6. Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study.
Gibbs P; Gebski V; Van Buskirk M; Thurston K; Cade DN; Van Hazel GA;
BMC Cancer; 2014 Dec; 14():897. PubMed ID: 25487708
[TBL] [Abstract][Full Text] [Related]
7. Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy.
Sharma RA; Van Hazel GA; Morgan B; Berry DP; Blanshard K; Price D; Bower G; Shannon JA; Gibbs P; Steward WP
J Clin Oncol; 2007 Mar; 25(9):1099-106. PubMed ID: 17369573
[TBL] [Abstract][Full Text] [Related]
8. Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases.
Jakobs TF; Hoffmann RT; Dehm K; Trumm C; Stemmler HJ; Tatsch K; La Fougere C; Murthy R; Helmberger TK; Reiser MF
J Vasc Interv Radiol; 2008 Aug; 19(8):1187-95. PubMed ID: 18656012
[TBL] [Abstract][Full Text] [Related]
9. Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy.
Hendlisz A; Van den Eynde M; Peeters M; Maleux G; Lambert B; Vannoote J; De Keukeleire K; Verslype C; Defreyne L; Van Cutsem E; Delatte P; Delaunoit T; Personeni N; Paesmans M; Van Laethem JL; Flamen P
J Clin Oncol; 2010 Aug; 28(23):3687-94. PubMed ID: 20567019
[TBL] [Abstract][Full Text] [Related]
10. Radioembolisation with Yttrium-90 microspheres: an effective treatment modality for unresectable liver metastases.
Bester L; Meteling B; Pocock N; Saxena A; Chua TC; Morris DL
J Med Imaging Radiat Oncol; 2013 Feb; 57(1):72-80. PubMed ID: 23374558
[TBL] [Abstract][Full Text] [Related]
11. Radioembolization and systemic chemotherapy improves response and survival for unresectable colorectal liver metastases.
Chua TC; Bester L; Saxena A; Morris DL
J Cancer Res Clin Oncol; 2011 May; 137(5):865-73. PubMed ID: 20859640
[TBL] [Abstract][Full Text] [Related]
12. Robust evidence for long-term survival with
Jakobs TF; Paprottka KJ; Raeßler F; Strobl F; Lehner S; Ilhan H; Trumm CG; Fendler WP; Sommer W; Paprottka PM
Eur Radiol; 2017 Jan; 27(1):113-119. PubMed ID: 27059858
[TBL] [Abstract][Full Text] [Related]
13. Yttrium-90 radioembolization as salvage therapy for colorectal cancer with liver metastases.
Martin LK; Cucci A; Wei L; Rose J; Blazer M; Schmidt C; Khabiri H; Bloomston M; Bekaii-Saab T
Clin Colorectal Cancer; 2012 Sep; 11(3):195-9. PubMed ID: 22277350
[TBL] [Abstract][Full Text] [Related]
14. Is yttrium-90 radioembolization a viable treatment option for unresectable, chemorefractory colorectal cancer liver metastases? A large single-center experience of 302 patients.
Saxena A; Meteling B; Kapoor J; Golani S; Morris DL; Bester L
Ann Surg Oncol; 2015 Mar; 22(3):794-802. PubMed ID: 25323474
[TBL] [Abstract][Full Text] [Related]
15. Glass yttrium-90 microspheres for patients with colorectal liver metastases.
Anderson JH; Goldberg JA; Bessent RG; Kerr DJ; McKillop JH; Stewart I; Cooke TG; McArdle CS
Radiother Oncol; 1992 Oct; 25(2):137-9. PubMed ID: 1438931
[TBL] [Abstract][Full Text] [Related]
16. Phase I trial of selective internal radiation therapy for chemorefractory colorectal cancer liver metastases progressing after hepatic arterial pump and systemic chemotherapy.
Sofocleous CT; Garcia AR; Pandit-Taskar N; Do KG; Brody LA; Petre EN; Capanu M; Longing AP; Chou JF; Carrasquillo JA; Kemeny NE
Clin Colorectal Cancer; 2014 Mar; 13(1):27-36. PubMed ID: 24370352
[TBL] [Abstract][Full Text] [Related]
17. Insights into the Dose-Response Relationship of Radioembolization with Resin 90Y-Microspheres: A Prospective Cohort Study in Patients with Colorectal Cancer Liver Metastases.
van den Hoven AF; Rosenbaum CE; Elias SG; de Jong HW; Koopman M; Verkooijen HM; Alavi A; van den Bosch MA; Lam MG
J Nucl Med; 2016 Jul; 57(7):1014-9. PubMed ID: 26912436
[TBL] [Abstract][Full Text] [Related]
18. Radioembolisation using yttrium 90 (Y-90) in patients affected by unresectable hepatic metastases.
Cianni R; Urigo C; Notarianni E; Saltarelli A; D'Agostini A; Iozzino M; Dornbusch T; Cortesi E
Radiol Med; 2010 Jun; 115(4):619-33. PubMed ID: 20091135
[TBL] [Abstract][Full Text] [Related]
19. Complete eradication of hepatic metastasis from colorectal cancer by Yttrium-90 SIRT.
Garrean S; Muhs A; Bui JT; Blend MJ; Owens C; Helton WS; Espat NJ
World J Gastroenterol; 2007 Jun; 13(21):3016-9. PubMed ID: 17589957
[TBL] [Abstract][Full Text] [Related]
20. Yttrium-90 radioembolization of renal cell carcinoma metastatic to the liver.
Abdelmaksoud MH; Louie JD; Hwang GL; Kothary N; Minor DR; Sze DY
J Vasc Interv Radiol; 2012 Mar; 23(3):323-30.e1. PubMed ID: 22277275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
